Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
5.43
0.69 (14.56%)
At close: Oct 03, 2025, 3:59 PM
5.30
-2.39%
After-hours: Oct 03, 2025, 07:48 PM EDT
Evaxion Biotech A/S Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Nov 14, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.19M | 3.3M | 3.35M | 3.3M | 278.37K | 124.48K | 73.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 3.19M | 3.3M | 3.35M | 3.3M | 278.37K | 124.48K | 73.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -13.97M | -14.21M | -14.72M | -15.06M | -19.09M | -20.19M | -22.2M | -24.36M | -24.68M | -25.26M | -25.27M | -26.46M | -26.29M | -27.06M | -25.83M | -22.76M | -21.53M | -18.45M |
Interest Income | -2.88M | -2.87M | 254K | 5.49M | 5.48M | 5.49M | 154K | 474K | 1.1M | 2.6M | 2.83M | 3.51M | 3.09M | 1.59M | 2.04M | 1.39M | 1.2M | 1.17M |
Pretax Income | -12.74M | -14.11M | -11.36M | -12.16M | -15.99M | -15.51M | -22.91M | -25.26M | -25.3M | -24.34M | -23.94M | -23.95M | -23.7M | -26.25M | -24.71M | -22.43M | -21.34M | -17.79M |
Net Income | -11.98M | -13.34M | -10.57M | -11.46M | -15.2M | -14.69M | -22.13M | -24.47M | -24.54M | -23.62M | -23.17M | -24.67M | -24.18M | -26.23M | -24.53M | -20.43M | -19.19M | -16.01M |
Selling & General & Admin | 7.65M | 7.42M | 7.31M | 7.88M | 8.68M | 9.44M | 10.37M | 10.67M | 9.75M | 9.16M | 8.21M | 7.32M | 6.8M | 6.57M | 6.26M | 6.48M | 6.71M | 6.16M |
Research & Development | 9.2M | 9.78M | 10.46M | 10.52M | 10.73M | 10.91M | 11.93M | 13.69M | 14.93M | 16.11M | 17.06M | 19.14M | 19.49M | 20.49M | 19.57M | 16.27M | 14.82M | 12.28M |
Other Expenses | 308.73K | 308.73K | 308.73K | 6.73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 71K | 71K | 71K | 71K | 12K | 12K | 12K |
Operating Expenses | 17.15M | 17.51M | 18.08M | 18.4M | 19.4M | 20.35M | 22.31M | 24.36M | 24.68M | 25.26M | 25.27M | 26.46M | 26.29M | 27.06M | 25.83M | 22.76M | 21.53M | 18.45M |
Interest Expense | 1.13M | 1.11M | 962K | 1.02M | 821K | 817K | 897K | 1.32M | 1.67M | 1.68M | 1.51M | 990K | 506K | 776K | 915K | 1.06M | 1.01M | 514K |
Selling & Marketing Expenses | n/a | -1.45K | -5.2K | 287.32K | 287.32K | 288.76K | 292.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.15M | 17.51M | 18.08M | 18.4M | 19.4M | 20.35M | 22.31M | 24.36M | 24.68M | 25.26M | 25.27M | 26.46M | 26.29M | 27.06M | 25.83M | 22.76M | 21.53M | 18.45M |
Income Tax Expense | -758.3K | -762.16K | -787.65K | -689.65K | -787.35K | -813.49K | -790K | -786K | -767K | -719K | -772K | 724K | 474K | -18K | -178K | -2M | -2.16M | -1.78M |
Shares Outstanding (Basic) | 4.83M | 1.11M | 1.07M | 1.38M | 1.35M | 1.17M | 683.39K | 691.5K | 676.55K | 644.6K | 603.49K | 595.84K | 580.1K | 579.1K | 541.78K | 479.97K | 473.54K | 444.89K |
Shares Outstanding (Diluted) | 4.83M | 1.11M | 1.07M | 1.38M | 1.35M | 1.17M | 683.39K | 691.5K | 676.55K | 644.6K | 603.49K | 595.84K | 596K | 579.1K | 541.78K | 479.97K | 473.54K | 444.89K |
EPS (Basic) | -7.2 | -10.8 | -8.4 | -11.6 | -18.4 | -22.2 | -32.8 | -37.6 | -39.2 | -39 | -39.2 | -43.2 | -44.6 | -50.8 | -50 | -45 | -44 | -37.2 |
EPS (Diluted) | -6.4 | -9.8 | -8.4 | -11.6 | -18.4 | -22.2 | -32.8 | -37.6 | -39.2 | -38.8 | -39 | -43 | -44.4 | -50.8 | -50 | -45 | -44 | -37.2 |
EBITDA | -13.41M | -13.11M | -10.52M | -8.75M | -12.66M | -13.81M | -21.16M | -23.83M | -23.63M | -22.68M | -22.42M | -23.59M | -23.84M | -26.14M | -24.46M | -21.4M | -20.44M | -17.38M |
EBIT | -13.41M | -13.21M | -10.61M | -9.54M | -13.58M | -14.69M | -22.02M | -24.65M | -24.34M | -23.37M | -23.14M | -23.71M | -23.95M | -26.23M | -24.55M | -21.57M | -20.53M | -17.47M |
Depreciation & Amortization | 180.21K | 280.21K | 280.21K | 189.46K | 300K | 350K | 439.25K | 528.5K | 369.75K | 261K | 213K | 165K | 150K | 116.75K | 83.5K | 71.25K | 70.33K | 82.58K |